Skip to main content
TipRanks
Go Ultimate75% OFF

D&M Co., Ltd. (189A) AI Stock Analysis

0 Followers
JP:189A

D&M Co., Ltd.

(TSE/TYO:189A)

Select Model
Rating:55Neutral
Price Target:JPY 1,076.00â–²(1.61% Upside)
Action:reiterated
Date:10/15/26

The score is held back primarily by weak financial quality: despite strong top-line growth and rising net income, D&M has not generated positive free cash flow since FY2022 and carries a heavy, rapidly growing debt load alongside compressing margins. Offsetting this, the stock trades at an undemanding 10.0x earnings with a 1.9% dividend yield and sits above its 50-, 100- and 200-day moving averages, indicating a positive longer-term trend, though near-term momentum has flattened. Until cash generation turns positive and leverage declines further, the risk profile keeps the overall rating around average.

Positive Factors
Revenue ExpansionThe substantial increase in revenue, including a particularly strong latest annual result, indicates that the company has expanded its business base and market activity. If this scale is retained, it can support operating leverage, broader customer reach, and continued investment in future growth.
Negative Factors
High LeverageHigh debt relative to equity leaves the company more exposed to refinancing needs, interest costs, and operating setbacks. Rising absolute debt also reduces financial flexibility, making it harder to absorb weaker conditions or fund expansion without continued reliance on lenders or other financing.

D&M Co., Ltd. (189A) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%JP:189A+5.23%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 2.44B
Dividend Yield
1.89%
Average Volume (3M)
3,360
Price to Earnings (P/E)
10.1
Beta (1Y)
0.31
Revenue Growth
8.02%
EPS Growth
9.50%
Country
Japan
Employees
68
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

D&M Co., Ltd. Business Overview & Revenue Model

Company Description

D & M Company Co., Ltd. engages in the provision of management support for people involved in the medical and long-term care welfare business. It offers finance and investment; consulting and business renovation; and Human Resource and outsourced ser...

D&M Co., Ltd. Financial Statement Overview

Summary

Revenue growth is impressive (¥930M in FY2022 to a projected ¥1.62B in FY2026, including 110.7% growth in the latest year) and net income has risen steadily to ¥222M. However, this expansion is debt-funded: total debt nearly doubled to ¥8.0B and debt-to-equity remains elevated at ~3.4x. Margins are compressing across the board (gross from ~69% to ~54%, EBIT from ~25% to ~17%). The weakest link is cash flow — operating cash flow has been negative in four of the last five years (¥-804M in FY2026) and free cash flow reached ¥-1.02B, signaling that reported profits are not converting into cash.

Income Statement

62Positive

Balance Sheet

35Negative

Cash Flow

18Very Negative
Financial statement breakdown
BreakdownTTMMay 2026May 2025May 2024May 2023May 2022
Income Statement
Total Revenue1.62B1.62B1.50B1.19B1.11B930.45M
Gross Profit934.42M871.68M845.89M754.83M655.71M640.68M
EBITDA340.27M287.15M310.20M288.27M242.34M238.65M
Net Income240.79M221.89M220.74M177.37M171.67M145.69M
Balance Sheet
Total Assets11.76B10.62B9.29B8.79B8.10B5.64B
Cash, Cash Equivalents and Short-Term Investments647.49M636.29M583.36M480.38M756.09M693.30M
Total Debt9.20B8.03B6.92B7.29B6.77B4.56B
Total Liabilities9.38B8.28B7.17B7.52B7.00B4.70B
Stockholders Equity2.38B2.35B2.12B1.27B1.10B937.89M
Cash Flow
Free Cash Flow-1.02B-1.02B-102.30M-784.82M-2.21B906.72M
Operating Cash Flow-804.09M-804.09M-69.76M-782.74M-2.19B911.23M
Investing Cash Flow-148.23M-148.23M-73.69M-20.59M45.95M32.38M
Financing Cash Flow1.11B1.11B250.22M509.20M2.17B-1.17B

D&M Co., Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price1059.00

Price Trends

50DMA1061.60Negative
100DMA1023.10Positive
200DMA974.17Positive

Market Momentum

MACD1.01Negative
RSI49.77Neutral
STOCH87.10Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:189A, the sentiment is Neutral. The current price of 1059.00 is below the 20-day moving average (MA) of 1060.35, below the 50-day MA of 1061.60, and above the 200-day MA of 974.17, indicating a neutral trend. The MACD of 1.01 indicates Negative momentum. The RSI at 49.77 is Neutral, neither overbought nor oversold. The STOCH value of 87.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:189A.

D&M Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:189A against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6062JP:606273OutperformJPY 64.01B14.43―2.19%5.50%45.42%
JP:9220JP:922070NeutralJPY 3.08B6.39―3.40%5.71%10.34%
JP:2373JP:237357NeutralJPY 5.21B18.02―4.46%4.76%-52.55%
JP:189AJP:189A55NeutralJPY 2.50B10.07―1.89%8.02%9.50%
JP:2425JP:242555NeutralJPY 2.50B28.45―3.34%-3.64%-66.52%
JP:7362JP:736255NeutralJPY 1.31B8.14――20.92%135.80%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%20%40%60%JP:189AJP:2373JP:2425JP:6062JP:7362JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:189A and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:189AD&M Co., Ltd.1059.0036.963.62%
JP:2373Care Twentyone Corporation381.00-47.26-11.04%
JP:2425Care Service Co., Ltd.659.00-103.11-13.53%
JP:6062Charm Care Corporation1963.00740.8760.62%
JP:7362Terminalcare Support Institute, Inc.856.0035.044.27%
JP:9220FB CARE SERVICE CO.,LTD.1265.0079.626.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 15, 2026